Code
365Q7813
Duration
15 December 2012 → 31 December 2013
Funding
Funding by bilateral agreement (private and foundations)
Promotor
Research disciplines
-
Natural sciences
- Genetics
- Systems biology
-
Medical and health sciences
- Laboratory medicine
- Medical systems biology
- Molecular and cell biology
- Laboratory medicine
- Medical systems biology
- Molecular and cell biology
- Laboratory medicine
- Medical systems biology
- Molecular and cell biology
Keywords
molecular
prognostic
jmml
relapse
RNA
non-coding
Project description
Juvenile myelomonocytic leukemia is an aggressive form of leukemia that affects infants and young children, with as only treatment option a stem cell transplantation. In this project, we wish to evaluatie whether non-coding RNA molecules can be used as diagnostic tool and prognostic markers or be potential therapeutic targets.